ammonium chloride

Small moleculeapproved

Approved

Nov 12, 1973

The ammonium cation is a positively charged polyatomic ion with the chemical formula NH4+. Ammonium ions are a waste product of the metabolism of animals. In fish and aquatic invertebrates, it is excreted directly into the water. In mammals, sharks, and amphibians, it is converted in the urea cycle to urea, because urea is less toxic and can be stored more efficiently. In birds, reptiles, and terrestrial snails, metabolic ammonium is converted into uric acid, which is solid and can therefore be excreted with minimal water loss. Ammonium is an important source of nitrogen for many plant species, especially those growing on hypoxic soils. However, it is also toxic to most crop species and is rarely applied as a sole nitrogen source. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium (Na+) to combine with fixed anions in maintaining acid-base balance, especially as a homeostatic compensatory mechanism in metabolic acidosis. When a loss of hydrogen ions (H+) occurs and serum chloride (Cl–) decreases, sodium is made available for combination with bicarbonate (HCO3–). This creates an excess of sodium bicarbonate (NaHCO3) which leads to a rise in blood pH and a state of metabolic alkalosis. The therapeutic effects of Ammonium (as Ammonium Chloride) depend upon the ability of the kidney to utilize ammonia in the excretion of an excess of fixed anions and the conversion of ammonia to urea by the liver, thereby liberating hydrogen (H+) and chloride (Cl–) ions into the extracellular fluid. — NCATS

Clinical trial activity

3 trials · 3 clinical orgs · 5 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Sep 30, 2003 (NCT00586131)

Timeline

1970s

  1. Nov 12, 1973

    Earliest FDA Approval

  2. Nov 12, 1973

    Abbott — Marketing Organization

  3. Oct 13, 1978

    B. Braun — Marketing Organization

1980s

  1. Jun 13, 1984

    Hospira — Marketing Organization

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Approval history

  • approvedNov 12, 1973

Chemistry & pharmacology

Loading structure…

SMILES

[NH4+]
Mol. weight
18.0385 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Prescription Only

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • ammonium chloride
  • chlorammonic
  • chlorammonic
  • e510
  • e510
  • tussi ammon co

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01440478Phase 1Sep 1, 2011Eli Lilly
NCT00946933N/ANov 1, 2009Queen's University, Belfast
NCT00586131Phase 4Sep 30, 2003University of California, Los Angeles
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eli LillyFor profit1112011
Queen's University, BelfastAcademic/Hospital1112009
University of California, Los AngelesAcademic/Hospital1112003
3 organizations
Page 1 / 1

Marketing (5)

OrganizationOrg typeRelationshipDate
AbbottFor profitMKTGNov 12, 1973
B. BraunFor profitMKTGOct 13, 1978
G D SearleFor profitMKTG
HospiraFor profitMKTGJun 13, 1984
Kendall McGaw LaboratoriesFor profitNDA2